secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2022-12-29T23:59:59+00:00
Accession:  0001213900-22-083446
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive terminates ATM equity offering agreement with JonesTrading, effective Jan 8, 2023
--------------------------------------------------------------------------------

- Terminated ATM equity offering with JonesTrading effective Jan 8, 2023; no sales since Dec 15, 2022.
- Originally announced Aug 15, 2022; allowed sales of up to $3M of common stock.
- Company cited limiting uncertainty and unfavorable dilution for shareholders as reason.
- No termination penalties; no further obligations after effective date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390022083446/0001213900-22-083446-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390022083446/ea170993-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-083446

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer